サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1424067

細胞治療市場、シェア、規模、動向、産業分析レポート：治療タイプ別、技術別、用途別、地域別、セグメント別予測、2024年～2032年

Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy Type (Allogeneic Therapies and Autologous Therapies); By Technology; By Application; By Region; Segment Forecast, 2024- 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
細胞治療市場、シェア、規模、動向、産業分析レポート：治療タイプ別、技術別、用途別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の細胞治療市場規模は2032年までに248億5,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

様々な慢性疾患の増加、世界の政府支援の増加、細胞治療の研究開発に多額の投資を行う企業の急増が、市場の成長を促進しています。加えて、個別化医療、再生医療、免疫療法における細胞治療の応用が拡大していることも、医療分野での細胞治療の存在感を高めています。

例えば、2024年1月、Pluri社は「PluriCDMO」と名付けた新事業部の立ち上げを発表しました。新事業部は、開発・製造受託機関のような細胞治療薬の製造サービスを提供します。

さらに、細胞治療のニーズは急激に高まっており、2022年のみで、約1,500件の細胞治療を含む臨床試験がClinicalTrials.govに登録されました。この需要の高まりに対応するため、企業は安全性、品質、有効性を維持しながら、これまでにない規模で細胞を生産しています。そのため、シングルユース・バイオリアクターや3Dバイオプリンティングなど、細胞生産における革新的なソリューションの導入が急ピッチで進んでいます。

3Dバイオプリンティングや自動化のような先進技術の細胞治療への統合は、大きな牽引力となっています。これらの技術は主に、全体的なスケーラビリティの向上、運用コストの削減、タイムリーで一貫性のある結果の提供を目的としているため、企業はますますこれらの技術を細胞治療に組み込もうとしています。例えば、2023年5月、Cellular Origins社は、完全自動化された設定可能なロボットプラットフォームであるConstellationの発売を発表しました。これは、大規模なプロセスの再開発を行うことなく、高度な治療法の製造を自動化するために特別に設計されたものです。

CAR-T細胞治療の採用が拡大し、より幅広い患者層に対するこれらの療法の安全性、有効性、用途の強化や改善に焦点を当てた研究活動が進行していることが、市場の成長をさらにエスカレートさせています。例えば、2023年12月、マックスヘルスケアはデリーの病院でイムノアクトと共同でCAR-T細胞治療を導入しました。

細胞治療市場レポートハイライト

遺伝性疾患の治療への採用増加により、自己細胞治療分野が最大シェアを占める

体細胞技術分野は、免疫療法におけるこの技術の利用が増加していることから、大きなシェアを占める見込み

筋骨格系分野は、世界の疾患の増加と世界の高齢化により、最も速いペースで成長します。

大手製薬会社の存在と細胞治療製造プロセスの進歩により、北米が世界市場を独占

主な市場プレイヤーは、Merck KGaA、Precision Biosciences、Becton, Dickinson, and Company、CRISPR Therapeutics、Thermo Fisher Scientificなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の細胞治療市場に関する洞察

  • 細胞治療市場- テクノロジースナップショット
  • 細胞治療市場力学
    • 促進要因と機会
      • 効果的または強力な治療法に対するニーズの高まりと、市場の成長を促進する個別化医療の受け入れの増加
      • 戦略的パートナーシップとコラボレーションが市場の成長を促進する可能性が高い
    • 抑制要因と課題
      • 高い開発コストと複雑な製造プロセスが市場の成長を抑制
  • PESTEL分析
  • 細胞治療市場の技術動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の細胞治療市場、用途別

  • 主な調査結果
  • イントロダクション
  • 筋骨格系
  • 心臓血管
  • 胃腸
  • 神経系
  • 腫瘍学
  • 皮膚科
  • 創傷
  • 眼科
  • その他

第6章 世界の細胞治療市場、治療タイプ別

  • 主な調査結果
  • イントロダクション
  • 同種療法
  • 自己療法

第7章 世界の細胞治療市場：技術別

  • 主な調査結果
  • イントロダクション
  • 体細胞技術
  • 細胞不死化技術
  • ウイルスベクター技術
  • ゲノム編集技術
  • 細胞可塑性技術

第8章 世界の細胞治療市場、地域別

  • 主な調査結果
  • イントロダクション
    • 細胞治療市場評価、地域別、2019-2032年
  • 細胞治療市場-北米
    • 北米：細胞治療市場、用途別、2019～2032年
    • 北米：細胞治療市場、技術別、2019-2032年
    • 北米：細胞治療市場、治療タイプ別、2019～2032年
    • 細胞治療市場-米国
    • 細胞治療市場- カナダ
  • 細胞治療市場- 欧州
    • 欧州：細胞治療市場、用途別、2019～2032年
    • 欧州：細胞治療市場、技術別、2019-2032
    • 欧州：細胞治療市場、治療タイプ別、2019～2032年
    • 細胞治療市場- 英国
    • 細胞治療市場- フランス
    • 細胞治療市場- ドイツ
    • 細胞治療市場- イタリア
    • 細胞治療市場- スペイン
    • 細胞治療市場- オランダ
    • 細胞治療市場- ロシア
  • 細胞治療市場- アジア太平洋
    • アジア太平洋：細胞治療市場、用途別、2019～2032年
    • アジア太平洋：細胞治療市場、技術別、2019～2032年
    • アジア太平洋：細胞治療市場、治療タイプ別、2019～2032年
    • 細胞治療市場- 中国
    • 細胞治療市場- インド
    • 細胞治療市場- マレーシア
    • 細胞治療市場- 日本
    • 細胞治療市場- インドネシア
    • 細胞治療市場- 韓国
  • 細胞治療市場-中東およびアフリカ
    • 中東およびアフリカ：細胞治療市場、用途別、2019～2032年
    • 中東およびアフリカ：細胞治療市場、技術別、2019-2032
    • 中東およびアフリカ：細胞治療市場、治療タイプ別、2019～2032年
    • 細胞治療市場- サウジアラビア
    • 細胞治療市場- アラブ首長国連邦
    • 細胞治療市場- イスラエル
    • 細胞治療市場- 南アフリカ
  • 細胞治療市場-ラテンアメリカ
    • ラテンアメリカ：細胞治療市場、用途別、2019～2032年
    • ラテンアメリカ：細胞治療市場、技術別、2019-2032
    • ラテンアメリカ：細胞治療市場、治療タイプ別、2019～2032年
    • 細胞治療市場- メキシコ
    • 細胞治療市場- ブラジル
    • 細胞治療市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Becton, Dickinson, and Company（US）
  • Bluebird Bio（US）
  • CRISPR Therapeutics（Switzerland）
  • Fate Therapeutics（US）
  • Lonza Group（Switzerland）
  • Merck KGaA（Germany）
  • Novartis AG（Switzerland）
  • Precision BioSciences（US）
  • Regeneron Pharmaceuticals（US）
  • Sartorius AG（Germany）
  • Takeda Pharmaceutical Company（Japan）
  • Thermo Fisher Scientific Inc.（US）
図表

List of Tables

  • Table 1 Global Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 2 Global Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 3 Global Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 4 Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 6 North America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 7 North America: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 8 U.S.: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 9 U.S.: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 11 Canada: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 12 Canada: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 14 Europe: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 15 Europe: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 17 UK: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 18 UK: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 19 UK: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 20 France: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 21 France: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 22 France: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 23 Germany: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 24 Germany: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 26 Italy: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 27 Italy: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 29 Spain: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 30 Spain: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 35 Russia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 36 Russia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 41 China: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 42 China: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 43 China: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 44 India: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 45 India: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 46 India: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 50 Japan: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 51 Japan: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 56 South Korea: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 57 South Korea: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 65 UAE: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 66 UAE: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 68 Israel: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 69 Israel: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 71 South Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 72 South Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 74 Latin America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 75 Latin America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 77 Mexico: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 78 Mexico: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 80 Brazil: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 81 Brazil: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 83 Argentina: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 84 Argentina: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cell Therapy Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapy Type
  • Figure 7. Global Cell Therapy Market, by Therapy Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Cell Therapy Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Cell Therapy Market, by Technology, 2022 & 2032 (USD Billion)
  • Figure 12. Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Cell Therapy Market
目次
Product Code: PM4331

The global cell therapy market size is expected to reach USD 24.85 billion by 2032, according to a new study by Polaris Market Research. The report "Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy Team (Allogeneic Therapies and Autologous Therapies); By Technology; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing prevalence of various chronic conditions, rising government assistance worldwide, and surge in the number of companies investing heavily in research & development of cell therapies, are driving the market's growth. Additionally, growing applications of cell therapies in personalized medicine, regenerative medicine, and immunotherapy making them more prominent in the medical field.

For instance, in January 2024, Pluri, announced the launch of its new business division named "PluriCDMO". The new business division will offer cell therapy manufacturing services like a contract development and manufacturing organization.

Furthermore, need for the cell therapies is growing drastically and in 2022 only, around 1,500 clinical trials involving cell therapies were registered with the ClinicalTrials.gov. In order to meet this rising demand, companies producing cells at unprecedented scale while maintaining the safety, quality, and efficacy. Thus, the incorporation of innovative solutions in cell production such as single-use bioreactors and 3D bioprinting are emerging at rapid pace.

The integration of advanced technologies like 3D bioprinting and automation into cell therapies is gaining huge traction. As these technologies mainly aimed at improving the overall scalability, reduce operational costs, and ensure timely & consistent delivery of results, companies are increasingly looking to integrate these technologies into their cell therapies. For instance, in May 2023, Cellular Origins, announced the launch of Constellation, a fully automated and configurable robotic platform. It is specially designed to automate the manufacturing of advanced therapies without major process redevelopment.

Growing adoption of CAR-T cell therapies and ongoing research activities focused on enhancing or improving the safety, efficacy, and applications of these therapies for broader patient population, further escalating the market's growth. For instance, in December 2023, Max Healthcare, introduced CAR-T cell therapy in collaboration with the ImmunoACT at its hospital in Delhi.

Cell Therapy Market Report Highlights

Autologous therapies segment accounted for largest share, on account of its increasing adoption for the treatment of genetic disorders

Somatic cell technology segment expected to hold significant share, due to rising usage of this technology in immunotherapies

Musculoskeletal segment will grow at fastest pace, that is attributed to rise in incidences of these conditions worldwide and global aging population

North America dominated the global market, owing to presence of large pharma companies and advancements in cell therapies manufacturing processes

The key market players include Merck KGaA, Precision Biosciences, Becton, Dickinson, and Company, CRISPR Therapeutics, and Thermo Fisher Scientific

Polaris Market Research has segmented the cell therapy market report based on therapy type, technology, application, and region:

Cell Therapy, Therapy Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • Allogeneic Therapies
  • Autologous Therapies

Cell Therapy, Technology Outlook (Revenue - USD Billion, 2023 - 2032)

  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Cell Plasticity Technology

Cell Therapy, Application Outlook (Revenue - USD Billion, 2023 - 2032)

  • Musculoskeletal
  • Cardiovascular
  • Gastrointestinal
  • Neurological
  • Oncology
  • Dermatology
  • Wound and Injuries
  • Ocular
  • Others

Cell Therapy, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cell Therapy Market Insights

  • 4.1. Cell Therapy Market - Technology Snapshot
  • 4.2. Cell Therapy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing need for effective or potent treatments and rising acceptance of personalized medicine to drive market's growth
      • 4.2.1.2. Strategic Partnerships & collaboration are likely to boost market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High development cost and complex manufacturing process to restrain the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cell Therapy Market Technology Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cell Therapy Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • 5.3. Musculoskeletal
    • 5.3.1. Global Cell Therapy Market, by Musculoskeletal, by Region, 2019-2032 (USD Billion)
  • 5.4. Cardiovascular
    • 5.4.1. Global Cell Therapy Market, by Cardiovascular, by Region, 2019-2032 (USD Billion)
  • 5.5. Gastrointestinal
    • 5.5.1. Global Cell Therapy Market, by Gastrointestinal, by Region, 2019-2032 (USD Billion)
  • 5.6. Neurological
    • 5.6.1. Global Cell Therapy Market, by Neurological, by Region, 2019-2032 (USD Billion)
  • 5.7. Oncology
    • 5.7.1. Global Cell Therapy Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 5.8. Dermatology
    • 5.8.1. Global Cell Therapy Market, by Dermatology, by Region, 2019-2032 (USD Billion)
  • 5.6. Wound and Injuries
    • 5.6.1. Global Cell Therapy Market, by Wound and Injuries, by Region, 2019-2032 (USD Billion)
  • 5.7. Ocular
    • 5.7.1. Global Cell Therapy Market, by Ocular, by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Cell Therapy Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Cell Therapy Market, by Therapy Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 6.3. Allogeneic Therapies
    • 6.3.1. Global Cell Therapy Market, by Allogeneic Therapies, by Region, 2019-2032 (USD Billion)
  • 6.4. Autologous Therapies
    • 6.4.1. Global Cell Therapy Market, by Autologous Therapies, by Region, 2019-2032 (USD Billion)

7. Global Cell Therapy Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • 7.3. Somatic Cell Technology
    • 7.3.1. Global Cell Therapy Market, by Somatic Cell Technology, By Region, 2019-2032 (USD Billion)
  • 7.4. Cell Immortalization Technology
    • 7.4.1. Global Cell Therapy Market, by Cell Immortalization Technology, By Region, 2019-2032 (USD Billion)
  • 7.5. Viral Vector Technology
    • 7.5.1. Global Cell Therapy Market, by Viral Vector Technology, By Region, 2019-2032 (USD Billion)
  • 7.6. Genome Editing Technology
    • 7.6.1. Global Cell Therapy Market, by Genome Editing Technology, By Region, 2019-2032 (USD Billion)
  • 7.7. Cell Plasticity Technology
    • 7.7.1. Global Cell Therapy Market, by Cell Plasticity Technology, By Region, 2019-2032 (USD Billion)

8. Global Cell Therapy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cell Therapy Market - North America
    • 8.3.1. North America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.3.4. Cell Therapy Market - U.S.
      • 8.3.4.1. U.S.: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.3.5. Cell Therapy Market - Canada
      • 8.3.5.1. Canada: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.4. Cell Therapy Market - Europe
    • 8.4.1. Europe: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.4. Cell Therapy Market - UK
      • 8.4.4.1. UK: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.5. Cell Therapy Market - France
      • 8.4.5.1. France: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.6. Cell Therapy Market - Germany
      • 8.4.6.1. Germany: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.7. Cell Therapy Market - Italy
      • 8.4.7.1. Italy: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.8. Cell Therapy Market - Spain
      • 8.4.8.1. Spain: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.9. Cell Therapy Market - Netherlands
      • 8.4.9.1. Netherlands: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.10. Cell Therapy Market - Russia
      • 8.4.10.1. Russia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.5. Cell Therapy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.4. Cell Therapy Market - China
      • 8.5.4.1. China: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.5. Cell Therapy Market - India
      • 8.5.5.1. India: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.6. Cell Therapy Market - Malaysia
      • 8.5.6.1. Malaysia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.7. Cell Therapy Market - Japan
      • 8.5.7.1. Japan: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.8. Cell Therapy Market - Indonesia
      • 8.5.8.1. Indonesia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.9. Cell Therapy Market - South Korea
      • 8.5.9.1. South Korea: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.6. Cell Therapy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.4. Cell Therapy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.5. Cell Therapy Market - UAE
      • 8.6.5.1. UAE: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.6. Cell Therapy Market - Israel
      • 8.6.6.1. Israel: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.7. Cell Therapy Market - South Africa
      • 8.6.7.1. South Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.7. Cell Therapy Market - Latin America
    • 8.7.1. Latin America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.7.4. Cell Therapy Market - Mexico
      • 8.7.4.1. Mexico: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.7.5. Cell Therapy Market - Brazil
      • 8.7.5.1. Brazil: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.7.6. Cell Therapy Market - Argentina
      • 8.7.6.1. Argentina: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Becton, Dickinson, and Company (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bluebird Bio (US)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. CRISPR Therapeutics (Switzerland)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Fate Therapeutics (US)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Lonza Group (Switzerland)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck KGaA (Germany)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Novartis AG (Switzerland)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Precision BioSciences (US)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Regeneron Pharmaceuticals (US)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sartorius AG (Germany)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Takeda Pharmaceutical Company (Japan)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Thermo Fisher Scientific Inc. (US)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development